News

The Observer1h
Ugandan firm to manufacture $28,000 HIV drug for just $50
In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...
Game-changer HIV shot approved in US may enter Canada by 2026; Just two injections a year
A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...
How big data and big deals may lead comebacks for Bay Area biotechs
New player emerges in 23andMe bankruptcy An Indian drug company has big plans for the East Bay An Indian drug company has big ...
‘Monumental’ HIV shot could be coming to Canada. What we know
Health-care experts and advocates say Gilead's HIV prevention shot could be a "wonder drug," but there is concerns about accessiblity.
'HBCUs have always had to think more strategically'
Opinion, comment and editorials of the day ...
US approves twice-yearly injection for HIV prevention. What you need to know about lenacapavir
The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...
FDA approves HIV drug based on University of Utah biochemist’s findings
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.
STAT18h
Vertex stem cell therapy spurs insulin independence
Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...
Gilead Sciences - Born With HIV in the 80s: Kim's Story of Growing Up as a Dandelion
NORTHAMPTON, MA / ACCESS Newswire / June 24, 2025 / Kim Canady was only nine years old in 1996 when she faced the ...
Ahram Online18h
The world’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...